In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $3.18 in the last session, up 0.95% from day before closing price of $3.15. In other words, the price has increased by $0.95 from its previous closing price. On the day, 2.82 million shares were traded. RCKT stock price reached its highest trading level at $3.25 during the session, while it also had its lowest trading level at $3.14.
Ratios:
We take a closer look at RCKT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On July 25, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $4.
Evercore ISI Downgraded its Outperform to In-line on May 30, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 27 ’25 when Bjork Elisabeth bought 10,000 shares for $3.41 per share. The transaction valued at 34,100 led to the insider holds 40,000 shares of the business.
Militello John sold 699 shares of RCKT for $2,142 on Aug 18 ’25. The insider now owns 56,285 shares after completing the transaction at $3.06 per share. On Aug 19 ’25, another insider, Militello John, who serves as the insider of the company, sold 361 shares for $3.00 each. As a result, the insider received 1,082 and left with 55,924 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 343134336 and an Enterprise Value of 96842312.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.68, which has changed by -0.8156522 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $18.89, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is -0.32%, while the 200-Day Moving Average is calculated to be -48.68%.
Shares Statistics:
According to the various share statistics, RCKT traded on average about 3.68M shares per day over the past 3-months and 2511200 shares per day over the past 10 days. A total of 107.88M shares are outstanding, with a floating share count of 98.68M. Insiders hold about 8.55% of the company’s shares, while institutions hold 85.78% stake in the company. Shares short for RCKT as of 1757894400 were 14892250 with a Short Ratio of 4.05, compared to 1755216000 on 11725943. Therefore, it implies a Short% of Shares Outstanding of 14892250 and a Short% of Float of 26.87.
Earnings Estimates
The firm’s stock currently is rated by 14.0 analysts. The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.33 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.69 and -$2.36 for the fiscal current year, implying an average EPS of -$2.13. EPS for the following year is -$1.16, with 13.0 analysts recommending between $0.69 and -$1.96.
